Better Value Health cover art

Better Value Health

Better Value Health

By: Setu Vora MD
Listen for free

About this listen

Brought to you by Setu Vora, MD who is currently the Chief Medical Officer of the Mashantucket Pequot Tribal Nation and Pequot Health Care. In this podcast we explore new ideas, challenges, and opportunities in healthcare in the United States. This podcast unlocks ways for American workers and employers to save lives and save money. We will talk with interesting and innovative leaders in this space about all things health and the business of healthcare in America.

© 2025 Better Value Health
Economics Hygiene & Healthy Living Leadership Management & Leadership Physical Illness & Disease
Episodes
  • Episode 13: Herb Boyd on Healing and Recovery
    Aug 18 2025

    Tribal Elder and Vice Chairman of the Elders Council, Herb Boyd shares his story, his journey in healing and strength. His lived experiences and his work in the recovery space gives hope and healing to so many.

    United States is going to spend over 6.8 Trillion dollars a year on healthcare by 2030. Almost 90% of employers think the cost of providing health benefits would be unsustainable in the next five to 10 years. Meanwhile, Americans have the highest maternal and infant mortality, the lowest life expectancy at birth, and the highest death rates for avoidable or treatable conditions among high-income countries.
    At Pequot Health Care, we work with innovative brokers, consultants, and employers who have had enough. Our mission at Pequot Health Care is to help people get Better Value Health.
    Through our independent Third Party Administration service along with our independent and truly transparent clinical pharmacy service, we help you bring down the giant costs- of diseases and of drugs. Visit us at pequothealthcare.com and let us talk about your wishes and ideas for Better Value Health.

    Show More Show Less
    21 mins
  • Episode 12: New Blood Test for Alzheimer's
    May 20 2025

    The U.S. Food and Drug Administration cleared for marketing the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer’s disease.

    The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is for the early detection of amyloid plaques associated with Alzheimer’s disease in adult patients, aged 55 years and older, exhibiting signs and symptoms of the disease.

    “Alzheimer’s disease impacts too many people, more than breast cancer and prostate cancer combined,” said FDA Commissioner Martin A. Makary, M.D., M.P.H. “Knowing that 10% of people aged 65 and older have Alzheimer's, and that by 2050 that number is expected to double, I am hopeful that new medical products such as this one will help patients.”

    What does this mean for the patients?

    The hope of early and reliable diagnosis.

    What does this mean for the health plans?

    Be prepared for more Rx volume and $$$ spend on the two approved specialty drugs- Leqembi or Kisunla. The total costs will go up.

    United States is going to spend over 6.8 Trillion dollars a year on healthcare by 2030. Almost 90% of employers think the cost of providing health benefits would be unsustainable in the next five to 10 years. Meanwhile, Americans have the highest maternal and infant mortality, the lowest life expectancy at birth, and the highest death rates for avoidable or treatable conditions among high-income countries.
    At Pequot Health Care, we work with innovative brokers, consultants, and employers who have had enough. Our mission at Pequot Health Care is to help people get Better Value Health.
    Through our independent Third Party Administration service along with our independent and truly transparent clinical pharmacy service, we help you bring down the giant costs- of diseases and of drugs. Visit us at pequothealthcare.com and let us talk about your wishes and ideas for Better Value Health.

    Show More Show Less
    23 mins
  • Episode 11: GLP1 gets the Award ! What's Next?
    Feb 6 2025

    Weight loss injections, game-changing diabetes drugs, and a multi-billion-dollar industry—GLP-1 medications have taken the world by storm. But how did we get here?

    In this podcast, we break down the history, scientific advances, and the recent Lasker Award given to the researchers behind these revolutionary drugs.GLP-1 drugs have reshaped medicine, from managing diabetes to redefining obesity treatment. The Lasker-winning researchers behind them have revolutionized how we think about metabolism, appetite, and health. But this is just the beginning. Where will this science take us next?"

    🚀 What do you think—are GLP-1s the future of weight loss and longevity, or just another pharmaceutical trend? Let’s discuss!

    🎧 Subscribe & Stay Tuned for More Science-Driven Insights!

    United States is going to spend over 6.8 Trillion dollars a year on healthcare by 2030. Almost 90% of employers think the cost of providing health benefits would be unsustainable in the next five to 10 years. Meanwhile, Americans have the highest maternal and infant mortality, the lowest life expectancy at birth, and the highest death rates for avoidable or treatable conditions among high-income countries.
    At Pequot Health Care, we work with innovative brokers, consultants, and employers who have had enough. Our mission at Pequot Health Care is to help people get Better Value Health.
    Through our independent Third Party Administration service along with our independent and truly transparent clinical pharmacy service, we help you bring down the giant costs- of diseases and of drugs. Visit us at pequothealthcare.com and let us talk about your wishes and ideas for Better Value Health.

    Show More Show Less
    17 mins
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.